Is there a need for standardization of methods in economic evaluations of medicines?

Medical Care

Volumn 34, Issue 12 SUPPL., 1996, Pages

  Rittenhouse, Brian E ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Economic evaluations; Guidelines; Standards

Indexed keywords

ARTICLE; HEALTH ECONOMICS; HEALTH SERVICES RESEARCH; HUMAN; PHARMACOECONOMICS; PRACTICE GUIDELINE; STANDARD;

ECONOMICS, MEDICAL; ECONOMICS, PHARMACEUTICAL; GUIDELINES; HEALTH SERVICES RESEARCH; HUMANS;

EID: 0030340404     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. CCOHTA. Guidelines for the economic evaluation of pharmaceuticals: canada - 1st ed. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 1994.
2. Mencken HL. Washingtonian 14 1978;Nov:155.
3. Hillman AL, Eisenberg JM, Pauly MV, et al. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med 1991;19:1362.
4. Rittenhouse B. The relevance of searching for effects under a clinical trial lamp post: A key issue. Medical Decision Making 1995:15:348.
5. Rittenhouse B, O'Brien B. Threats to the validity of pharmacoeconomic analysis based on clinical trial data. In: Spilker, B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven Publishers, 1996.
6. Schecter CB. Decision analysis in formulary decision making. PharmacoEconomics 1993;3:454.
7. Drummond M. Lecture and discussions on international standardization. Tokyo, Japan: Institute for Health Economics and Policy, 1995.
8. O'Brien B, Drummond MF, LaBelle RJ, Willan A. In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care 1994;32:150.
9. Hornberger, JC, Redelmeier DA, Petersen J. Variability among methods to assess patients'well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992;45:505.
10. Sloan F. Valuing Health Care. Cambridge: Cambridge University Press, 1995.
11. Drummond MF, Torrance GW, Mason J. Cost-effectiveness league tables: More harm than good? Social Science and Medicine 1993;37:33.
12. McNeil BJ, Pauker SG, Sox HC Jr, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med 1982;306:1259.